We remain deeply committed to developing new and improved treatments for complications from the disease to meet the evolving needs of the CF community.
We continue to make significant progress toward these goals, supporting an innovative research portfolio and collaborating with top scientists from around the world to deliver the next generation of transformative breakthroughs in CF. In 2023, the Foundation advanced these efforts by funding approximately $243 million in laboratory research, preclinical drug development, and clinical and real-world research — the largest amount to date.
Our Research Funding
The CF Foundation spent a total of $243.3 million on research and development as well as the CF Foundation Therapeutics Lab in 2023.
***
Reference to any specific product, process, or service does not necessarily constitute or imply its endorsement, recommendation, or favoring by the Cystic Fibrosis Foundation. The appearance of external hyperlinks does not constitute endorsement by the Cystic Fibrosis Foundation of the linked websites, or information, products, or services contained therein.
Information contained on this site does not cover all possible uses, actions, precautions, side effects, or interactions. This site is not intended as a substitute for treatment advice from a medical professional. Consult your doctor before making any changes to your treatment.
FDA-approved drug information is available at dailymed.nlm.nih.gov/dailymed.